...
首页> 外文期刊>The biochemical journal >High-content screening of feeder-free human embryonic stem cells to identify pro-survival small molecules
【24h】

High-content screening of feeder-free human embryonic stem cells to identify pro-survival small molecules

机译:高内涵无饲养层人类胚胎干细胞的筛选,以鉴定存活前的小分子

获取原文
           

摘要

pThe propensity of human embryonic stem cells to die upon enzymatic disaggregation or low-density plating is an obstacle to their isolation and routine use in drug discovery and basic research. Equally, the very low rate of establishment of implanted cells hinders cell therapy. In the present study we have developed a high-content assay for human embryonic stem cell survival and used this to screen a range of libraries of ‘lead-like’ small molecules and known bioactives. From this we identified 18 confirmed hits with four structural classes being represented by multiple compounds: a series of 5-(acyl/alkyl-amino)indazoles, compounds with a 4-(acylamino)pyridine core, simple iN/isupi6/i/sup,iN/isupi6/i/sup-dialkyladenines and compounds with a 5-(acylamino)indolinone core. iIn vitro/i kinase profiling indicated that the ROCK (Rho-associated kinase)/PRK2 (protein kinase C-related kinase 2) protein kinases are of pivotal importance for cell survival and identified previously unreported compound classes that inhibited this important biological activity. An evaluation using an extensive panel of protein kinases showed that six of our hit compounds exhibited better selectivity for ROCK inhibition than the routinely used commercially available ROCK inhibitor Y-27632. In this screen we also identified the Ksup+/sup-ATP channel opener pinacidil and show that it probably promotes cell survival, by ‘off-target’ inhibition of ROCK/PRK2. We have therefore identified novel pro-survival compounds of greater specificity, equivalent potency and reduced toxicity relative to the routinely employed ROCK inhibitor Y-27632./p
机译:>人类胚胎干细胞倾向于在酶解或低密度平板接种后死亡,这是其在药物发现和基础研究中分离和常规使用的障碍。同样,极低的植入细胞建立率也阻碍了细胞治疗。在本研究中,我们开发了一种用于人类胚胎干细胞存活的高含量检测方法,并将其用于筛选一系列“铅样”小分子和已知生物活性物质的库。据此,我们确定了18种经确认的命中,具有由多种化合物代表的四个结构类别:一系列5-(酰基/烷基-氨基)吲唑,具有4-(酰基氨基)吡啶核的化合物,简单的 N 6 , N 6 -二烷基丁烯和具有5-(酰基氨基的化合物)吲哚酮核心体外激酶分析表明ROCK(Rho相关激酶)/ PRK2(蛋白激酶C相关激酶2)蛋白激酶对于细胞存活至关重要,并确定了以前未报道的可抑制这种情况的化合物类别重要的生物活性。使用广泛的蛋白激酶评估表明,与常规使用的市售ROCK抑制剂Y-27632相比,我们的六个命中化合物具有更好的ROCK抑制选择性。在该屏幕中,我们还鉴定出K + -ATP通道开放剂Pinacidil,并表明它可能通过“脱靶”抑制ROCK / PRK2来促进细胞存活。因此,我们确定了相对于常规使用的ROCK抑制剂Y-27632具有更高的特异性,同等效力和更低的毒性的新型存活前化合物。
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号